← The library
Research only

KPV

aka α-MSH (11-13)

A 3-amino-acid fragment of a natural hormone — acts like a chill pill for inflammation.

Technically · Tripeptide anti-inflammatory

inflammationgut healthskin
KPV
The vial
KPV 2D molecular structure
The moleculeCID 18934

In one sentence

A three-amino-acid fire extinguisher for inflammation — blocks the master switch (NFκB) that drives chronic disease.

If BPC-157 is the construction crew, KPV is the firefighter. Skips repair, kills inflammation.

Half-life

Short (hours)

A few hours active — daily dosing.

Dosing

Daily SubQ; can stack with BPC-157/TB-500

How often you take a dose

Route

SubQ · Oral

How it goes into the body

Status

Research

Sold for lab research — not approved for humans

Education only. Many compounds discussed are research chemicals not approved for human use in the US. This is not medical advice — consult a licensed physician.

What it is

A tiny three-amino-acid piece (Lys-Pro-Val) of your body's α-MSH hormone. It quiets one of the most important inflammation switches (NFκB). Used for autoimmune calming, gut healing, and skin inflammation. Strong anecdotal results in gut and skin issues.

The full technical answer

A three-amino-acid C-terminal fragment of α-melanocyte-stimulating hormone (Lys-Pro-Val). Acts as an NFκB blocker — the master inflammation switch. Used for autoimmune calming and gut healing.

How it works

Imagine inflammation as a fire alarm system, and NFκB is the master alarm switch. When NFκB flips on, dozens of inflammatory signals follow. KPV blocks that switch. The fire alarm doesn't go off, so the cascade of inflammation never starts.

The full technical answer

Blocks NFκB transcription factor activation, reducing pro-inflammatory cytokine cascades. Hunter Williams describes it as a "fire extinguisher" for inflammation versus BPC-157's "construction crew" repair.

ExtracellularInside the cellNFκB blockadeReceptorpeptidedownstream signaling
Receptors hit: NFκB blockade. The peptide binds the receptor on the cell surface, triggering downstream signaling inside the cell.

What the research says

Animal and in-vitro data for inflammatory bowel disease, allergic inflammation, and autoimmune calming. Limited human RCTs. Strong anecdotal data in peptide community for gut and skin inflammation.

Sources: PubMed: KPV anti-inflammatory

Common dosing ranges

Range
200–500 mcg/day
Frequency
Daily SubQ; can stack with BPC-157/TB-500
Duration
4–6 weeks on / 2–4 weeks off (Bachmeyer)

Sources: PubMed

How to take it

Practical guidance synthesized from clinical protocols, FDA labels, and clinician interviews. Always cross-check with a prescribing physician.

Best time of day

AM, daily. Some users dose twice daily (AM + PM) for active gut flares.

With food or fasted

Doesn't matter for SubQ. Oral KPV is also used for gut-specific effects — take fasted for gut benefit.

How long to cycle

4–6 weeks on, 2–4 weeks off (Bachmeyer protocol). Stack with BPC-157 + TB-500 in advanced gut/autoimmune cycles.

When to get off

End each cycle on schedule. Long-term continuous use in healthy people isn't studied.

Administration

SubQ
Oral

Side effects

Common

  • Generally well-tolerated
  • Minimal reported

Serious / theoretical

  • Long-term safety in healthy users not established

Sources: PubMed

Notes

Hunter Williams rates KPV above BPC-157 specifically for inflammation. Stacks with BPC-157 + TB-500 in advanced gut/autoimmune protocols.

Further reading & listening

Where the experts go deeper.

Curated from the PeptideFacts expert directory — vetted YouTube channels, podcasts, books, and communities. No anecdote-only or supplier-affiliated picks.

Often compared